Growth opportunities amidst intensifying competition.The European active pharmaceutical ingredients market

摘要

This article provides an overview of the European active pharmaceutical ingredients (API) market.The fragmented and highly competitive market presents many challenges to API manufacturers such as overcapacity,lack of capability differentiation and low cost competition from Asian manufacturers.This article provides strategies on tackling major challenges and enumerates elements of business planning and monitoring for a comprehensive approach.An integrated plan based on speedy delivery and cost competitiveness can be implemented for efficient API manufacturing and enhanced profit margins.The highly fragmented European active pharmaceutical ingredients (API) market comprises both domestic and international manufacturers.Chemical producers dominate this crowded competitive landscape,accounting for a majority of the market share.At the same time,several small manufacturers are active in niche segments.However,increasing consolidations are rationalising the industry structure.All major pharmaceutical companies have their own manufacturing capacities.However,many pharmaceutical companies perceive outsourcing API manufacture as a cost-effective approach to building additional capacity.